Wetting Kinetics of Molten 60Sn40Pb on a Ag-0.33 wt.% Pt Thick Film Conductor

1995 ◽  
Vol 117 (3) ◽  
pp. 241-245 ◽  
Author(s):  
J. Campbell ◽  
H. Conrad
Keyword(s):  
Contact Angle ◽  
Thick Film ◽  
Sessile Drop ◽  
Stage Ii ◽  
Stage Iii ◽  
Effect Of Temperature ◽  
Solid Alloy ◽  
Spherical Cap ◽  
Time Exponent ◽  
Wetting Kinetics

The effects of time (10-6000 s) and temperature (194°-265°C) on the wetting of a Ag-0.33 wt percent Pt thick film (10 μm) conductor substrate by molten 60Sn40Pb were investigated using the sessile drop method. The wetting occurred in three stages. In Stage I the solid alloy piece melted and spread rapidly to form a spherical cap. The spreading slowed down appreciably in Stage II but increased again in Stage III, the time exponent in Stage III being of the order of 0.1–0.25, which was 2–3 times that in Stage II. In general, the contact angle θ and the time exponent decreased with temperature. The activation energy for the effect of temperature on the contact angle in Stages II and III and on the transition time tc between these stages was approximately 7 kcal/mole. This value was concluded to represent the diffusion of Sn atoms over the halo surface as a precursor to the formation of the intermetallic compound Ag3Sn at the molten solder/substrate interface.

Spreading Kinetics of Molten 60Sn40Pb on Higher Melting Temperature Pb-Sn Alloy Substrates

1995 ◽  
Vol 390 ◽  
Author(s):  
H. Conrad ◽  
Z. Guo ◽  
D. Y. Jung
Keyword(s):  
Activation Energy ◽  
Contact Angle ◽  
Melting Point ◽  
Kcal Mole ◽  
Depth Of Penetration ◽  
Spherical Cap ◽  
Solid Diffusion ◽  
Time Exponent ◽  
Image Position ◽  
Kinetics Of

ABSTRACTThe spreading of molten 60Sn40Pb drops on higher melting point Pb-Sn alloy substrates (3 to 10 wt.% Sn) was investigated for reflow temperatures of 205° to 300°C. Following melting the drop assumed the form of a slightly flared, spherical cap with some penetration into the substrate beneath the contact area. The effects of time and temperature on the contact angle θ and the depth of penetration h were of the formwhere the apparent activation energy Q was 4.2 kcal/mole for θ and 16 kcal/mole for h. The time exponent m (negative for θ and positive for h) decreased with temperature from ∼ 0.2–0.3 at 205°C to ∼0.05 at 260° and then increased again at higher temperatures. The magnitude of Q for θ is in accord with that for the viscosity of molten Pb-Sn alloys and that for h with a combined liquid-solid diffusion involved in the dissolution. Further work is however needed to identify unequivocally the mechanisms which govern the wetting in these duplex Pb-Sn alloy systems.

Wetting of Compacted Nanoclay Powder by Epoxy Resin

Materials ◽  
2005 ◽  
Author(s):  
Levent Aktas ◽  
Youssef K. Hamidi ◽  
M. Cengiz Altan
Keyword(s):  
Contact Angle ◽  
Epoxy Resin ◽  
Sessile Drop ◽  
Ccd Camera ◽  
Contact Angles ◽  
Effect Of Temperature ◽  
Chemical Compositions ◽  
Low Viscosity ◽  
Static Contact ◽  
Advancing Contact Angle

Spreading behavior and advancing contact angle of a low viscosity epoxy resin on three commercially available nanoclays — Cloisite® Na+, Cloisite® 15A and Cloisite® 25A — at 52°C is investigated. In addition, effect of temperature on spreading dynamics of epoxy on Cloisite® Na+ is analyzed at 33, 52 and 77°C. For wetting experiments, nanoclay powder is compressed into 12.7mm diameter disk shaped compacts under 20MPa pressure. The surface topologies of the compacts are analyzed by scanning electron microscopy (SEM), where as energy dispersive x-ray analysis (EDXA) is utilized to quantify the chemical composition of the surface. An epoxy drop is placed on each of the compacts and spreading is monitored via a CCD camera equipped with a high magnification lens. Temporal evolution of the advancing contact angle as well as drop penetration into the nanoclay compact is determined using the drop profiles extracted from the sessile drop images. Spreading of epoxy on Cloisite® Na+ is observed to be 12-fold faster at 77°C compared to 33°C. Analogous to its spreading speed, rate of penetration of resin into the nanoclay compact increased 20-fold in the same temperature range. Behavior of different nanoclay types are assessed by repeating the wetting experiments on Cloisite® 15A and Cloisite® 25A compacts. Unlike Cloisite® Na+, which did not have a finite static contact angle, Cloisite® 15A and Cloisite® 25A yielded static contact angles of 59.2°and 40.1°, respectively. These differences are attributed to different surface energies as a result of different chemical compositions of the surfaces and dissimilar surface topologies.

Identification of biomarkers and functional modules from genomic data in stage-wise breast cancer

2020 ◽  
Vol 15 ◽  
Author(s):  
Athira K ◽  
Vrinda C ◽  
Sunil Kumar P V ◽  
Gopakumar G
Keyword(s):  
Breast Cancer ◽  
Expression Patterns ◽  
Differential Expression Analysis ◽  
Predictive Biomarkers ◽  
Stage I ◽  
Stage Ii ◽  
Stage Iii ◽  
Functional Modules ◽  
Incidence And Mortality ◽  
Multiple Stages

Background: Breast cancer is the most common cancer in women across the world, with high incidence and mortality rates. Being a heterogeneous disease, gene expression profiling based analysis plays a significant role in understanding breast cancer. Since expression patterns of patients belonging to the same stage of breast cancer vary considerably, an integrated stage-wise analysis involving multiple samples is expected to give more comprehensive results and understanding of breast cancer. Objective: The objective of this study is to detect functionally significant modules from gene co-expression network of cancerous tissues and to extract prognostic genes related to multiple stages of breast cancer. Methods: To achieve this, a multiplex framework is modelled to map the multiple stages of breast cancer, which is followed by a modularity optimization method to identify functional modules from it. These functional modules are found to enrich many Gene Ontology terms significantly that are associated with cancer. Result and Discussion: predictive biomarkers are identified based on differential expression analysis of multiple stages of breast cancer. Conclusion: Our analysis identified 13 stage-I specific genes, 12 stage-II specific genes, and 42 stage-III specific genes that are significantly regulated and could be promising targets of breast cancer therapy. That apart, we could identify 29, 18 and 26 lncRNAs specific to stage I, stage II and stage III respectively.

Cardiac transthyretin wild-type amyloidosis (ATTRwt): a prospective study of 400 patients followed at the Italian referral center

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
P Milani ◽  
L Obici ◽  
R Mussinelli ◽  
M Basset ◽  
G Manfrinato ◽  
...  
Keyword(s):  
Natural History ◽  
Median Survival ◽  
Troponin I ◽  
Stage I ◽  
Stage Ii ◽  
Stage Iii ◽  
Wild Type ◽  
Staging Systems ◽  
Significant Difference ◽  
History Of

Abstract Background Cardiac wild type transthyretin (ATTRwt) amyloidosis, formerly known as senile systemic amyloidosis, is an increasingly recognized, progressive, and fatal cardiomyopathy. Two biomarkers staging systems were proposed based on NT-proBNP (in both cases) and troponin or estimated glomerular filtration rate, that are able to predict survival in this population. The availability of novel effective treatments requires large studies to describe the natural history of the disease in different populations. Objective To describe the natural history of the disease in a large, prospective, national series. Methods Starting in 2007, we protocolized data collection in all the patients diagnosed at our center (n=400 up to 7/2019). Results The referrals to our center increased over time: 5 cases (1%) between 2007–2009, 33 (9%) in 2010–2012, 90 (22%) in 2013–2015 and 272 (68%) in 2016–2019. Median age was 76 years [interquartile range (IQR): 71–80 years] and 372 patients (93%) were males. One hundred and seventy-three (43%) had atrial fibrillation, 63 (15%) had a history of ischemic cardiomyopathy and 64 (15%) underwent pacemaker or ICD implantation. NYHA class was I in 58 subjects (16%), II in 225 (63%) and III in 74 (21%). Median NT-proBNP was 3064 ng/L (IQR: 1817–5579 ng/L), troponin I 0.096 ng/mL (IQR: 0.063–0.158 ng/mL), eGFR 62 mL/min (IQR: 50–78 mL/min). Median IVS was 17 mm (IQR: 15–19 mm), PW 16 mm (IQR: 14–18 mm) and EF 53% (IQR: 45–57%). One-hundred and forty-eight subjects (37%) had a concomitant monoclonal component in serum and/or urine and/or an abnormal free light chain ratio. In these patients, the diagnosis was confirmed by immunoelectron microscopy or mass spectrometry. In 252 (63%) the diagnosis was based on bone scintigraphy. DNA analysis for amyloidogenic mutations in transthyretin and apolipoprotein A-I genes was negative in all subjects. The median survival of the whole cohort was 59 months. The Mayo Clinic staging based on NT-proBNP (cutoff: 3000 ng/L) and troponin I (cutoff: 0.1 ng/mL) discriminated 3 different groups [stage I: 131 (35%), stage II: 123 (32%) and stage III: 127 (33%)] with different survival between stage I and II (median 86 vs. 81 months, P=0.04) and between stage II and III (median 81 vs. 62 months, P<0.001). The UK staging system (NT-proBNP 3000 ng/L and eGFR 45 mL/min), discriminated three groups [stage I: 170 (45%), stage II: 165 (43%) and stage III: 45 (12%)] with a significant difference in survival: between stage I and stage II (86 vs. 52 months, P<0.001) and between stage II and stage III (median survival 52 vs. 33 months, P=0.045). Conclusions This is one of the largest series of patients with cardiac ATTRwt reported so far. Referrals and diagnoses increased exponentially in recent years, One-third of patients has a concomitant monoclonal gammopathy and needed tissue typing. Both the current staging systems offered good discrimination of staging and were validated in our independent cohort. Funding Acknowledgement Type of funding source: None

The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients

2021 ◽  
Author(s):  
Kosuke Mima ◽  
Nobutomo Miyanari ◽  
Keisuke Kosumi ◽  
Takuya Tajiri ◽  
Kosuke Kanemitsu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
High Risk ◽  
Adjuvant Chemotherapy ◽  
Stage Ii ◽  
Stage Iii ◽  
Frail Patients

scholarly journals CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling

Cancers ◽  
2021 ◽  
Vol 13 (14) ◽  
pp. 3568
Author(s):  
Hina Mir ◽  
Neeraj Kapur ◽  
Dominique N. Gales ◽  
Praveen K. Sharma ◽  
Gabriela Oprea-Ilies ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Actin Polymerization ◽  
Biological Significance ◽  
Stage Ii ◽  
Stage Iii ◽  
Soluble Form ◽  
Migration And Invasion ◽  
Antibody Microarray ◽  
Terminal Fragment ◽  
Significant Difference

Precise mechanisms underlying breast cancer (BrCa) metastasis are undefined, which becomes a challenge for effective treatments. Chemokine signaling instigates the trafficking of cancer cells in addition to leukocytes. This study aimed to ascertain the clinical and biological significance of the CXCR6/CXCL16 signaling axis in the pathobiology of BrCa. Our data show a higher expression of CXCR6 in BrCa cell lines and tissues. Stage-III BrCa tissues express significantly higher CXCR6 compared to stage-II tissues. The ligand, CXCL16, could remain tethered to the cell surface, and, after proteolytic shedding of the ectodomain, the N-terminal fragment is released, converting it to its oncogenic, soluble form. Like CXCR6, N-terminal CXCL16 and ADAM-10 were significantly higher in stage-III than stage-II, but no significant difference was observed in the C-terminal fragment of CXCL16. Further, stimulation of the CXCR6/CXCL16 axis activated Src, FAK, ERK1/2, and PI3K signaling pathways, as per antibody microarray analysis, which also underlie CXCL16-induced F-actin polymerization. The CXCR6/CXCL16 axis induces cytoskeleton rearrangement facilitating migration and invasion and supports BrCa cell survival by activating the PI3K/Akt pathway. This study highlights the significance of the CXCR6/CXCL16 axis and ADAM10 as potential therapeutic targets for advanced-stage BrCa.

Comparative studies of nitrogen plasma and argon plasma treatment on the strength of PBO fibre reinforced high-temperature resistant thermoplastic composite

2021 ◽  
pp. 095400832098729
Author(s):  
K Sudheendra ◽  
Jennifer Vinodhini ◽  
M Govindaraju ◽  
Shantanu Bhowmik
Keyword(s):  
Contact Angle ◽  
High Temperature ◽  
Plasma Treatment ◽  
Sessile Drop ◽  
Dynamic Contact Angle ◽  
Argon Plasma ◽  
Film Surface ◽  
Fibre Surface ◽  
Nitrogen Plasma ◽  
Thermoplastic Composite

The study involves the processing of a novel poly [1, 4-phenylene-cis-benzobisoxazole] (PBO) fibre reinforced high-temperature thermoplastic composite with polyaryletherketone (PAEK) as the matrix. The PBO fibre and the PAEK film surface was modified using the method of argon and nitrogen plasma treatment. The investigation primarily focuses on evaluating the tensile properties of the fabricated laminates and correlating it with the effect of plasma treatment, surface characteristics, and its fracture surface. A 5% decrease in tensile strength was observed post argon plasma treatment while a 27% increase in strength was observed post nitrogen plasma treatment. The morphology of the failure surface was investigated by scanning electron microscopy and an interfacial failure was observed. Furthermore, the effect of plasma on the wettability of PBO fibres and PAEK film surface was confirmed by the Dynamic Contact Angle analysis and sessile drop method respectively. FTIR spectral analysis was done to investigate the effect of plasma treatment on the chemical structure on the surface. The results of the wettability study showed that the argon plasma treatment of the fibre surface increased its hydrophobicity while nitrogen plasma treatment resulted in the reduction of contact angle.

Single Ventricle Palliation in a Developing Sub-Saharan African Country: What Should be Improved?

2019 ◽  
Vol 10 (2) ◽  
pp. 164-170 ◽  
Author(s):  
Valdano Manuel ◽  
Humberto Morais ◽  
Aida L. R. Turquetto ◽  
Gade Miguel ◽  
Leonardo A. Miana ◽  
...  
Keyword(s):  
Confidence Interval ◽  
African Country ◽  
Single Ventricle ◽  
Hazard Ratio ◽  
Stage I ◽  
Stage Ii ◽  
Stage Iii ◽  
Lost To Follow Up ◽  
Single Ventricle Palliation

Introduction: Single ventricle physiology management is challenging, especially in low-income countries. Objective: To report the palliation outcomes of single ventricle patients in a developing African country. Methods: We retrospectively studied 83 consecutive patients subjected to single ventricle palliation in a single center between March 2011 and December 2017. Preoperative data, surgical factors, postoperative results, and survival outcomes were analyzed. The patients were divided by palliation stage: I (pulmonary artery banding [PAB] or Blalock–Taussig shunt [BTS]), II (Glenn procedure), or III (Fontan procedure). Results: Of the 83 patients who underwent palliation (stages I-III), 38 deaths were observed (31 after stage I, six after stage II, and one after stage III) for an overall mortality of 45.7%. The main causes of operative mortality were multiple organ dysfunction due to sepsis, shunt occlusion, and cardiogenic shock. Twenty-eight survivors were lost to follow-up (22 after stage I, six after stage II). Thirteen stage II survivors are still waiting for stage III. The mean follow-up was 366 ± 369 days. Five-year survival was 28.4 % for PAB and 30.1% for BTS, while that for stage II and III was 49.8% and 57.1%, respectively. Age (hazard ratio, 0.61; 95% confidence interval: 0.47-0.7; P = .000) and weight at surgery (hazard ratio, 0.45; 95% confidence interval: 0.31-0.64; P = .002) impacted survival. Conclusion: A high-mortality rate was observed in this initial experience, mainly in stage I patients. A large number of patients were lost to follow-up. A task force to improve outcomes is urgently required.

Sign in / Sign up

Export Citation Format

Share Document